Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.
Urinary tract infection agent yields positive phase III study results
December 2nd 2013Ceftolozane/tazobactam, an investigational antibiotic, showed positive top-line results in a pivotal phase III clinical trial of the drug’s use in complicated urinary tract infections, Cubist Pharmaceuticals, Inc. reported.
ASTRO, AAFP Choosing Wisely lists target prostate cancer, urinary tract infection
September 30th 2013The American Society for Radiation Oncology and the American Academy of Family Physicians have both released recommendations on the diagnosis and treatment of prostate cancer as part of the Choosing Wisely campaign.